Anhui Anke BioTech Group (300009) — Cash Flow Reinvestment Rate
Anhui Anke BioTech Group (300009) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥21.63 Million (capex CN¥21.63 Million ) from operating cash flow of CN¥240.51 Million. Explore 300009 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Anke BioTech Group Cash Flow Reinvestment Rate (2006–2024)
Historical reinvestment intensity for Anhui Anke BioTech Group across 19 annual periods. Also explore Anhui Anke BioTech Group asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Anhui Anke BioTech Group (2006–2024)
Year-by-year capital reinvestment analysis for Anhui Anke BioTech Group. For live market cap and broader valuation context, see 300009 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.26x | CN¥174.93 Million | CN¥685.37 Million | CN¥117.22 Million | ▼ -59.3% |
| 2023 | 0.63x | CN¥617.17 Million | CN¥985.01 Million | CN¥195.34 Million | ▼ -23.9% |
| 2022 | 0.82x | CN¥575.41 Million | CN¥698.98 Million | CN¥474.34 Million | ▲ +108.1% |
| 2021 | 0.40x | CN¥234.30 Million | CN¥592.17 Million | CN¥131.23 Million | ▼ -52.8% |
| 2020 | 0.84x | CN¥389.76 Million | CN¥464.80 Million | CN¥138.52 Million | ▼ -63.8% |
| 2019 | 2.32x | CN¥684.87 Million | CN¥295.63 Million | CN¥186.48 Million | ▲ +190.7% |
| 2018 | 0.80x | CN¥229.13 Million | CN¥287.49 Million | CN¥213.72 Million | ▼ -4.5% |
| 2017 | 0.83x | CN¥234.17 Million | CN¥280.63 Million | CN¥131.78 Million | ▲ +207.4% |
| 2016 | 0.27x | CN¥70.04 Million | CN¥258.01 Million | CN¥69.18 Million | ▼ -75.4% |
| 2015 | 1.10x | CN¥131.05 Million | CN¥118.73 Million | CN¥36.95 Million | ▲ +36.3% |
| 2014 | 0.81x | CN¥88.04 Million | CN¥108.68 Million | CN¥88.04 Million | ▲ +36.3% |
| 2013 | 0.59x | CN¥31.64 Million | CN¥53.21 Million | CN¥31.64 Million | ▼ -46.2% |
| 2012 | 1.10x | CN¥59.42 Million | CN¥53.80 Million | CN¥59.42 Million | ▼ -90.4% |
| 2011 | 11.49x | CN¥82.54 Million | CN¥7.18 Million | CN¥82.54 Million | ▲ +4776.0% |
| 2010 | 0.24x | CN¥11.18 Million | CN¥47.43 Million | CN¥11.18 Million | ▼ -27.3% |
| 2009 | 0.32x | CN¥12.54 Million | CN¥38.67 Million | CN¥12.54 Million | ▲ +29.4% |
| 2008 | 0.25x | CN¥6.52 Million | CN¥26.04 Million | CN¥6.52 Million | ▼ -5.7% |
| 2007 | 0.27x | CN¥9.32 Million | CN¥35.10 Million | CN¥9.32 Million | ▲ +206.2% |
| 2006 | 0.09x | CN¥2.57 Million | CN¥29.66 Million | CN¥2.57 Million | — |